Ekso Bionics HoldingsEKSO -0.42%32 Days Inventory is 404.98 as of Mar. 2026, which is 117% above its 10-year median of 186.84. GuruFocus rates EKSO with a GF Score™ of 32/100 and a GF Value™ of $4.38 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Ekso Bionics Holdings ranks worse than 81.81% on this metric.
The historical rank and industry rank for Ekso Bionics Holdings's Days Inventory or its related term are showing as below:
EKSO'
s Days Inventory Range Over the Past 10 Years
Min: 42.28 Med: 186.84 Max: 333.33
Current: 333.33
During the past 13 years, Ekso Bionics Holdings's highest Days Inventory was 333.33. The lowest was 42.28. And the median was 186.84.
EKSO's Days Inventory is ranked worse than 81.81% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.785
vs EKSO: 333.33
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Ekso Bionics Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ekso Bionics Holdings's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 2.21.
Ekso Bionics Holdings (NAS:EKSO) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Ekso Bionics Holdings's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Ekso Bionics Holdings's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Ekso Bionics Holdings Days Inventory Related Terms
Ekso Bionics Holdings Days Inventory Historical Data
* Premium members only.
The historical data trend for Ekso Bionics Holdings's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKSO vs POCI, HBIO, NEPH: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ekso Bionics Holdings Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Ekso Bionics Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ekso Bionics Holdings (EKSO) has a Days Inventory of 404.98 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ekso Bionics Holdings and its competitors. This is 117% above median its historical median of 186.84. Over the past decade, Ekso Bionics Holdings' Days Inventory has ranged from 42.28 to 333.33. According to the industry distribution chart, Ekso Bionics Holdings ranks #643 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 81.8%.
Is Ekso Bionics Holdings' Days Inventory too high?
Ekso Bionics Holdings' current Days Inventory of 404.98 is 117% above median its 10-year median of 186.84. Over the past 10 years, this metric has ranged from a low of 42.28 to a high of 333.33. The Medical Devices & Instruments industry median Days Inventory is 179.79. Ekso Bionics Holdings' value of 404.98 is 125.3% above this industry median. Based on the distribution chart, Ekso Bionics Holdings ranks #643 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ekso Bionics Holdings has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ekso Bionics Holdings' Days Inventory compare to POCI and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Ekso Bionics Holdings ranks #643 out of 786 companies for Days Inventory. This places Ekso Bionics Holdings in the lower half of its industry. The industry median Days Inventory is 179.79. Ekso Bionics Holdings' value of 404.98 is 125.3% above this benchmark. Historically, Ekso Bionics Holdings' own Days Inventory has ranged from 42.28 to 333.33 over the past decade. While the company's 10-year median is 186.84 vs. the industry median of 179.79, Ekso Bionics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.79, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ekso Bionics Holdings's current Days Inventory of 404.98 is 125.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Ekso Bionics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ekso Bionics Holdings's current Days Inventory is 404.98, which is 117% above median its own 10-year median of 186.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ekso Bionics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ekso Bionics Holdings (EKSO) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.38, compared to a current price of $11.65 — trading 166% above its estimated fair value. The current Days Inventory is 404.98, which is 117% above median its 10-year median of 186.84 and 125.3% above the Medical Devices & Instruments industry median of 179.79. Ekso Bionics Holdings' overall GF Score™ is 32/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Ekso Bionics Holdings (EKSO), the current Days Inventory is 404.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ekso Bionics Holdings (EKSO) Overvalued in 2026?
Based on GuruFocus' analysis, Ekso Bionics Holdings stock appears to be overvalued.
The current stock price of $11.65 is trading 166% above its estimated GF Value™ of $4.38.
GuruFocus considers Ekso Bionics Holdings to be Significantly Overvalued.
Key valuation signals for EKSO:
Days Inventory: 404.98 (117% above median its 10-year median of 186.84)
GF Value™: $4.38 vs. price of $11.65 (166% above fair value)
Industry Position: 125.3% above the Medical Devices & Instruments median (#643 of 786)
No single metric tells the full story. See the EKSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
32GF Score
Get the complete analysis for EKSO
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKSO has been successfully added to your 
